1. Home
    2. Mhra

    Understanding the MHRA and CBD Regulation in the UK

    Image showing a logo with a royal coat of arms and text reading "Medicines & Healthcare products Regulatory Agency." A gloved hand holds a cannabis leaf on the right side of the image.
    Trusted and regulated! 🌿✨ Ensuring safe healthcare products. #MHRA #CannabisSafety

    Navigating the Complexities of CBD Regulation in the UK with MHRA

    The Medicines and Healthcare Products Regulatory Agency (MHRA) plays a pivotal role in maintaining the safety, quality, and efficacy of medical products in the UK, including Cannabidiol (CBD). Whether you're a consumer or a business owner in the CBD sector, understanding the MHRA’s regulations is crucial to ensure compliance and protect public health.

    1. Role of MHRA

    The MHRA is an executive agency sponsored by the Department of Health and Social Care. Its primary mission is to safeguard public health by ensuring that medicines, medical devices, and blood components for transfusion meet stringent standards. For the CBD market, their oversight ensures that products are safe, effective, and marketed responsibly.

    2. Regulation of CBD Products

    Since 2020, CBD products, especially those intended for human consumption, are regulated under the Novel Foods Regulation. This means that food products infused with CBD must undergo a rigorous authorisation process before they can be legally sold in the UK. The Food Standards Agency (FSA) oversees the application process for these products, ensuring compliance with set standards.

    Key Areas Addressed by MHRA:

    • Market Surveillance: The MHRA conducts regular market surveillance to ensure that all products comply with current regulations. They are tasked with the designation and monitoring of UK Approved Bodies responsible for certifying these products.
    • Licensing: Products must have a valid Product Licence (marketing authorisation) before they can be placed on the market unless they are specifically exempt.
    • Compliance with Human Medicines Regulations 2012: Any CBD product used for a medical purpose must satisfy these legal standards before commercial release.
    • Toxicological Data: Any novel food application must include toxicological information that reflects the composition of the product seeking authorisation.

    3. Consumer Safety and CBD

    The MHRA is ardent about ensuring public safety. Every CBD product on the market must pass stringent safety checks. For instance, CBD food products:

    • Must be labelled correctly: Incorrect labelling or making unverified health claims can lead to severe penalties.
    • Must not be unsafe: Products that do not meet safety standards are withdrawn from the market.
    • Should not be controlled substances: The correct classification and absence of controlled substances ensure products are legal and safe for consumption.

    4. CBD Novel Food Applications

    The novel food status for CBD was confirmed in January 2019. Thus, all CBD food products require authorisation before they can be sold legally. Businesses must apply for authorisation of their CBD extracts and associated products to be placed on the market using a regulated product application service. Important elements of this application process include:

    • Validation: Meeting the validation standard, which is required before progressing towards final authorisation, does not automatically guarantee approval.
    • Toxicological Studies: Comprehensive toxicological studies must be submitted, and the use of animals for these studies should be minimal. Data used should reflect international toxicological methods and consideration of product safety.

    5. Marketing and Advertisement of CBD Products

    The MHRA sets clear guidelines for the marketing of CBD products:

    • Health and Medicinal Claims: It is prohibited to make unverified health or medicinal claims unless the product is licensed as a medicine by the MHRA. Businesses often inadvertently breach this critical regulation.
    • Authorisation Compliance: Only CBD food products listed under validated or sufficiently progressing novel food applications can be marketed pending a final decision on authorisation.

    6. Ensuring Compliance

    To maintain quality and compliance:

    • Businesses must stay updated on regulatory changes: Regularly review guidelines and modifications to ensure all products meet current standards.
    • Local Authority Enforcement: Local authorities are responsible for market enforcement and may remove non-compliant products from the shelves.
    • Consumer Feedback: Continuous feedback from consumers helps businesses remain informed about their product safety and quality.

    7. Public Health and CBD Consumption

    The FSA has issued consumer advice on the consumption of CBD for healthy adults and vulnerable groups. Sellers must inform consumers about the maximum recommended daily limit for healthy adults and advise caution or seek medical advice in the case of vulnerable groups such as children, pregnant women, or those on medication.

    Summary

    The MHRA’s regulation of CBD products in the UK is designed to protect public health and ensure product safety and efficacy. Businesses must comply with the rigorous standards and processes set out by the MHRA and FSA, ensuring their products meet legal and safety requirements before hitting the market. If you’re considering entering the CBD market or looking to understand how your business can remain compliant, keeping abreast of MHRA guidelines will be pivotal in your success.